PE20010579A1 - Mesoprogestinas (modulares de receptores de progesterona) como componentes de anticonceptivos femeninos - Google Patents
Mesoprogestinas (modulares de receptores de progesterona) como componentes de anticonceptivos femeninosInfo
- Publication number
- PE20010579A1 PE20010579A1 PE2000000894A PE0008942000A PE20010579A1 PE 20010579 A1 PE20010579 A1 PE 20010579A1 PE 2000000894 A PE2000000894 A PE 2000000894A PE 0008942000 A PE0008942000 A PE 0008942000A PE 20010579 A1 PE20010579 A1 PE 20010579A1
- Authority
- PE
- Peru
- Prior art keywords
- mesoprogestines
- modulars
- components
- progesterone receptor
- female contraceptives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38613399A | 1999-08-31 | 1999-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20010579A1 true PE20010579A1 (es) | 2001-06-04 |
Family
ID=23524305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2000000894A PE20010579A1 (es) | 1999-08-31 | 2000-08-31 | Mesoprogestinas (modulares de receptores de progesterona) como componentes de anticonceptivos femeninos |
Country Status (28)
Country | Link |
---|---|
EP (1) | EP1605949A2 (hu) |
JP (1) | JP2003511399A (hu) |
KR (1) | KR20020038745A (hu) |
CN (1) | CN1384748A (hu) |
AR (1) | AR025455A1 (hu) |
AU (1) | AU781835B2 (hu) |
BG (1) | BG106441A (hu) |
BR (1) | BR0013711A (hu) |
CA (1) | CA2383650A1 (hu) |
CO (1) | CO5190694A1 (hu) |
CZ (1) | CZ2002707A3 (hu) |
EA (1) | EA006805B1 (hu) |
EE (1) | EE200200103A (hu) |
HR (1) | HRP20020265A2 (hu) |
HU (1) | HUP0202515A3 (hu) |
IL (1) | IL148415A0 (hu) |
LT (1) | LT5001B (hu) |
LV (1) | LV12940B (hu) |
MX (1) | MXPA02002186A (hu) |
NO (1) | NO20020998L (hu) |
NZ (1) | NZ517470A (hu) |
PE (1) | PE20010579A1 (hu) |
PL (1) | PL353994A1 (hu) |
SI (1) | SI20853A (hu) |
SK (1) | SK2982002A3 (hu) |
UA (1) | UA77150C2 (hu) |
WO (1) | WO2001026603A2 (hu) |
YU (1) | YU13902A (hu) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10236405A1 (de) | 2002-08-02 | 2004-02-19 | Schering Ag | Progesteronrezeptormodulatoren mit erhöhter antigonadotroper Aktivität für die weibliche Fertilitätskontrolle und Hormonersatztherapie |
AU2003255355A1 (en) * | 2002-08-02 | 2004-02-25 | Schering Aktiengesellschaft | Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy |
US7772219B2 (en) * | 2003-05-02 | 2010-08-10 | Teva Women's Health, Inc. | Methods of hormonal treatment utilizing extended cycle contraceptive regimens |
US20050215535A1 (en) * | 2004-03-24 | 2005-09-29 | Kristof Chwalisz | Sequential SPRM/progestin treatment |
EP1773344A1 (en) * | 2004-07-07 | 2007-04-18 | Wyeth a Corporation of the State of Delaware | Cyclic progestin regimens and kits |
DE102005050729A1 (de) * | 2005-10-19 | 2007-04-26 | Schering Ag | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
ES2602134T3 (es) | 2009-04-14 | 2017-02-17 | Laboratoire Hra Pharma | Procedimiento para anticoncepción bajo demanda |
CN110548034A (zh) * | 2019-07-12 | 2019-12-10 | 广州莎蔓生物科技有限公司 | 一种怀孕阻断药物 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2054271A (en) | 1932-05-17 | 1936-09-15 | Schering Kahlbaum Ag | Production of crystallized hormone esters |
DE699310C (de) | 1936-11-20 | 1940-11-27 | Chemische Ind Ges | Verfahren zur Herstellung von in 3-Stellung veresterten Verbindungen vom Typus des Oestradiols |
US2225419A (en) | 1937-03-01 | 1940-12-17 | Schering Corp | Process for the conversion of 17-cisalcohols of the cyclopentanopolyhydrophenanthrene series into the corresponding 17-trans-alcohols |
US2611773A (en) | 1951-08-21 | 1952-09-23 | Upjohn Co | Estradiol 17-cyclopenetanepropionate |
US2990414A (en) | 1957-03-26 | 1961-06-27 | Syntex Sa | 17-undecenoate of estradiol |
DE3337450A1 (de) | 1983-10-12 | 1985-04-25 | Schering AG, 1000 Berlin und 4709 Bergkamen | Prostaglandine und antigestagene fuer den schwangerschaftsabbruch |
DK174071B1 (da) * | 1987-09-24 | 2002-05-21 | Jencap Res Ltd | Kontraceptivt præparat i form af en pakning omfattende enhedsdoser |
US5439913A (en) | 1992-05-12 | 1995-08-08 | Schering Aktiengesellschaft | Contraception method using competitive progesterone antagonists and novel compounds useful therein |
US5516769A (en) | 1993-02-19 | 1996-05-14 | The Medical College Of Hampton Roads | Method of inhibiting fertilization |
DE4332284C2 (de) * | 1993-09-20 | 1997-05-28 | Jenapharm Gmbh | 11-Benzaldoxim-17beta-methoxy-17alpha-methoxymethyl-estradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE4332283A1 (de) | 1993-09-20 | 1995-04-13 | Jenapharm Gmbh | Neue 11-Benzaldoximestradien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE4429398C2 (de) | 1994-08-09 | 1997-09-11 | Jenapharm Gmbh | Verwendung von Estra-1,3,5(10)-trien-Derivaten zur hormonalen Kontrazeption |
DE4429397C2 (de) | 1994-08-09 | 2003-11-20 | Jenapharm Gmbh | Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen |
NZ295365A (en) * | 1994-10-24 | 1999-07-29 | Schering Ag | Competitive progesterone antagonists for regulating female fertility as required |
US6040340A (en) * | 1996-05-07 | 2000-03-21 | Schering Aktiengesellschaft | Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors |
CA2255863A1 (en) * | 1996-06-25 | 1997-12-31 | Akzo Nobel Nv | Progestogen-anti-progestogen regimens |
WO1998005679A2 (en) * | 1996-08-05 | 1998-02-12 | Duke University | Mixed agonists of the progesterone receptor and assays therefor |
DE19809845A1 (de) * | 1998-03-03 | 1999-09-09 | Jenapharm Gmbh | S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen |
CA2371273A1 (en) * | 1999-05-04 | 2000-11-09 | Andrew Fensome | Tetracyclic progesterone receptor modulator compounds and methods |
-
2000
- 2000-08-31 KR KR1020027002785A patent/KR20020038745A/ko not_active Application Discontinuation
- 2000-08-31 WO PCT/IB2000/002053 patent/WO2001026603A2/en not_active Application Discontinuation
- 2000-08-31 EA EA200200284A patent/EA006805B1/ru not_active IP Right Cessation
- 2000-08-31 IL IL14841500A patent/IL148415A0/xx unknown
- 2000-08-31 CA CA002383650A patent/CA2383650A1/en not_active Abandoned
- 2000-08-31 NZ NZ517470A patent/NZ517470A/en unknown
- 2000-08-31 BR BR0013711-1A patent/BR0013711A/pt not_active IP Right Cessation
- 2000-08-31 PE PE2000000894A patent/PE20010579A1/es not_active Application Discontinuation
- 2000-08-31 YU YU13902A patent/YU13902A/sh unknown
- 2000-08-31 CZ CZ2002707A patent/CZ2002707A3/cs unknown
- 2000-08-31 EE EEP200200103A patent/EE200200103A/xx unknown
- 2000-08-31 EP EP00991299A patent/EP1605949A2/en not_active Withdrawn
- 2000-08-31 PL PL00353994A patent/PL353994A1/xx not_active Application Discontinuation
- 2000-08-31 UA UA2002032429A patent/UA77150C2/uk unknown
- 2000-08-31 CO CO00065517A patent/CO5190694A1/es not_active Application Discontinuation
- 2000-08-31 JP JP2001529395A patent/JP2003511399A/ja active Pending
- 2000-08-31 AU AU32150/01A patent/AU781835B2/en not_active Ceased
- 2000-08-31 AR ARP000104536A patent/AR025455A1/es unknown
- 2000-08-31 HU HU0202515A patent/HUP0202515A3/hu unknown
- 2000-08-31 MX MXPA02002186A patent/MXPA02002186A/es not_active Application Discontinuation
- 2000-08-31 SK SK298-2002A patent/SK2982002A3/sk unknown
- 2000-08-31 CN CN00812308A patent/CN1384748A/zh active Pending
- 2000-08-31 SI SI200020043A patent/SI20853A/sl not_active IP Right Cessation
-
2002
- 2002-02-26 BG BG06441A patent/BG106441A/bg unknown
- 2002-02-28 NO NO20020998A patent/NO20020998L/no not_active Application Discontinuation
- 2002-03-26 LT LT2002035A patent/LT5001B/lt not_active IP Right Cessation
- 2002-03-28 LV LVP-02-52A patent/LV12940B/en unknown
- 2002-03-28 HR HR20020265A patent/HRP20020265A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
BR0013711A (pt) | 2002-05-07 |
BG106441A (bg) | 2002-09-30 |
CN1384748A (zh) | 2002-12-11 |
YU13902A (sh) | 2006-01-16 |
NZ517470A (en) | 2004-03-26 |
AR025455A1 (es) | 2002-11-27 |
HUP0202515A3 (en) | 2004-06-28 |
WO2001026603A2 (en) | 2001-04-19 |
AU781835B2 (en) | 2005-06-16 |
CZ2002707A3 (cs) | 2002-11-13 |
HRP20020265A2 (en) | 2004-02-29 |
HUP0202515A2 (hu) | 2002-12-28 |
NO20020998D0 (no) | 2002-02-28 |
UA77150C2 (en) | 2006-11-15 |
KR20020038745A (ko) | 2002-05-23 |
NO20020998L (no) | 2002-03-14 |
CA2383650A1 (en) | 2001-04-19 |
EP1605949A2 (en) | 2005-12-21 |
JP2003511399A (ja) | 2003-03-25 |
LT2002035A (lt) | 2002-10-25 |
MXPA02002186A (es) | 2002-09-02 |
EA006805B1 (ru) | 2006-04-28 |
SK2982002A3 (en) | 2002-07-02 |
EA200200284A1 (ru) | 2002-10-31 |
PL353994A1 (en) | 2003-12-15 |
SI20853A (sl) | 2002-10-31 |
LT5001B (lt) | 2003-03-25 |
AU3215001A (en) | 2001-04-23 |
EE200200103A (et) | 2003-04-15 |
LV12940B (en) | 2003-06-20 |
CO5190694A1 (es) | 2002-08-29 |
WO2001026603A3 (en) | 2002-01-17 |
IL148415A0 (en) | 2002-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR970706001A (ko) | 습식-과립화를 통해 투여단위를 제조하는 방법 (process of making dosage units by wet granulation) | |
BRPI0512991A (pt) | uso de uma progestina, kit farmaceuticamente útil adaptado para a administração oral diária, e, método de contracepção em uma fêmea em idade de parto | |
AR011480A1 (es) | ACIL-ANILIDAS SUSTITUIDAS CON RADICALES (HETERO) CICLICOS, NO ESTEROIDALES, CON ACTIVIDAD GESTÁGENA Y ANDRoGENA MIXTA. | |
RS50972B (sr) | Farmaceutski sastav koji sadrži gestagene i/ili estrogene i 5-metil-(6s)-tetrahidrofolate | |
TW200605880A (en) | Progesterone receptor antagonist contraceptive regimens and kits | |
AU560487B2 (en) | Contraceptive comprising gestodene and ethinylestradiol | |
ECSP055629A (es) | COMPOSICIÓN QUE CONTIENE UN ESTEROIDE 11ß-HALOGENADO ANDRÓGENO Y UN GESTÁGENO ASÍ COMO UN CONTRACEPTIVO MASCULINO SOBRE LA BASE DE ESTAS COMPOSICIONES | |
PE20060127A1 (es) | Sistema de entrega de farmacos constituido por copolimero de polietileno acetato de vinilo | |
BRPI0116793B8 (pt) | produtos de hormônio de esteróide e métodos para prepará-los | |
AP9801384A0 (en) | Improvements of implantation rates after in vitro fertilization. | |
CY1105276T1 (el) | Τριφασικο στοματικο αντισυλληπτικο | |
DK0868188T3 (da) | Kontraceptionskit til hunpattedyr bestående af en kombination af gestagen og estrogen | |
ECSP084358A (es) | NUEVAS FORMAS SÓLIDAS DE LA MESOPROGESTINA 11ß-[4E-(HIDROXIIMINOMETIL)-FENIL]- 17ALFA-METOXIMETIL-17ß-METOXI-ESTRA-4,9-DIEN-3-ONA | |
DE122007000011I1 (de) | Feste Arzneiformen, enthaltend Clathrate vom steroidalen Sexualhormon Ethinylestradiol | |
ES2114605T3 (es) | Metodo anticonceptivo que emplea un antagonista de progesterona competitivo y nuevos compuestos utilizados en el. | |
CR7611A (es) | Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona | |
PE20010579A1 (es) | Mesoprogestinas (modulares de receptores de progesterona) como componentes de anticonceptivos femeninos | |
CO5631449A2 (es) | Nuevos esteres de etonogestrel | |
BR9911344A (pt) | Composto, undecanoato de ment, uso do mesmo, formulação farmacêutica, e, kit para a contracepção masculina. | |
AU1967300A (en) | Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11 | |
IT1154735B (it) | Derivati d'amino-14 steroidi e procedimento per la loro preparazione | |
Hahn et al. | The pharmacological profile of norgestimate, a new orally active progestin | |
CU23414B7 (es) | Estratrienos 9-alfa-sustituidos como estrógenos de eficacia selectiva | |
PE20010581A1 (es) | Mesoprogestinas (modulares de receptores de progesterona) como componentes de composiciones utilizadas para la terapia de sustitucion hormonal (hrt) | |
BR0112791A (pt) | Composto esteroidal 16alfa-substituido, uso do mesmo, métodos de tratamento para ativação seletiva de receptores de estrogênio do subtipo alfa, e para terapia de reposição hormonal ou contracepção, e, composição farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |